Congressional Investigation of Pharmacy Rebates on Medicaid Drugs
Client Alert | less than 1 min read | 01.16.04
The House Energy and Commerce Committee and its Subcommittee on Oversight and Investigations have asked five large retail pharmacy chains for documents on pharmaceutical reimbursements and rebates under Medicaid. The committee is concerned that drug manufacturers may have been engaged in improper "marketing of the spread," to the detriment of state Medicaid programs. The letters expressed concern that drug manufacturers could be charging low prices on particular prescription medications to their customers, while submitting inaccurate or incomplete cost or price information that becomes the basis of state Medicaid reimbursement for the drug at much higher prices. The January 14th letters were sent to CVS, Eckerd, Rite Aid, Walgreen, and Wal-Mart.
Contacts
Insights
Client Alert | 8 min read | 11.16.26
OCC’s AI Examiner Framework: How Banks’ AI Use Can Trigger Legal Liability and Supervisory Exposure
On November 4, 2026, the Office of the Comptroller of the Currency (OCC) issued Bulletin 2026-54 and a Supervisory Framework on Bank Use of Super Intelligence (the “Framework”), an examiner resource addressing banks’ use of artificial intelligence (AI), particularly generative AI and AI agents that can act on their own. The Framework creates no new legal requirements or supervisory expectations, and the OCC states that banks are not expected to use it to assess their own AI use or risk management. Importantly, it identifies as higher risk several AI uses common for banks that are already governed by binding law, such as moving money, making credit decisions, and communicating with customers. A failure in any of those uses could trigger legal liability. Institutions that rely on AI for these tasks should consider the following:
Client Alert | 3 min read | 11.13.26
Massachusetts Trade Secret Preliminary Injunctions: Prove the Harm, Tailor the Relief
Client Alert | 1 min read | 11.12.26
SBA Announces Doubling Veteran Contracting Target to 10% for FY 2027, but Questions Remain
Client Alert | 6 min read | 11.12.26

